Univo Pharmaceuticals Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
UNVO
IL0010935588
Biotechnology & Medical Research
Sales 2019 | 0.82 2.99 | Sales 2020 | 33.68 122.24 | Capitalization | 75.1M 273M |
---|---|---|---|---|---|
Net income 2019 | -11M -39.92M | Net income 2020 | - 0 | EV / Sales 2019 | 35,543,010 x |
Net cash position 2019 | 22.82M 82.83M | Net Debt 2020 | 4.12M 14.95M | EV / Sales 2020 | 2,352,105 x |
P/E ratio 2019 * |
-
| P/E ratio 2020 |
-
| Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 59.28% |
Managers | Title | Age | Since |
---|---|---|---|
Golan Bitton
CEO | Chief Executive Officer | 48 | 93-04-03 |
Jonathan Eilat
IRC | Investor Relations Contact | - | - |
Noam Frakash
AUD | Comptroller/Controller/Auditor | 41 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chaim Hurvitz
CHM | Chairman | 64 | 19-07-14 |
Golan Bitton
CEO | Chief Executive Officer | 48 | 93-04-03 |
1st Jan change | Capi. | |
---|---|---|
+24.74% | 47.54B | |
-0.47% | 41.96B | |
+48.49% | 41.55B | |
+25.40% | 30.36B | |
+17.96% | 27.61B | |
-4.47% | 28.7B | |
+50.73% | 14.7B | |
+42.56% | 13.51B | |
+1.46% | 12.34B |